Welcome to LookChem.com Sign In|Join Free
  • or
isopropyl 4-[(3S,5aR,6R,7R,8aS)-7-hydroxy-6-[(E,3R)-3-hydroxy-4-phenoxy-but-1-enyl]-3,4,5,5a,6,7,8,8a-octahydro-2H-cyclopenta[b]oxepin-3-yl]butanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1262872-82-1

Post Buying Request

1262872-82-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1262872-82-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1262872-82-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,2,8,7 and 2 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1262872-82:
(9*1)+(8*2)+(7*6)+(6*2)+(5*8)+(4*7)+(3*2)+(2*8)+(1*2)=171
171 % 10 = 1
So 1262872-82-1 is a valid CAS Registry Number.

1262872-82-1Upstream product

1262872-82-1Relevant academic research and scientific papers

Discovery of novel seven-membered prostacyclin analogues as potent and selective prostaglandin FP and EP3 Dual Agonists

Sugimoto, Isamu,Kambe, Tohru,Okino, Tomotaka,Obitsu, Tetsuo,Ohta, Nobukazu,Nishiyama, Taihei,Kinoshita, Akihiro,Fujimoto, Taku,Egashira, Hiromu,Yamane, Shinsaku,Shuto, Satoshi,Tani, Kousuke,Maruyama, Toru

supporting information, p. 107 - 112 (2017/12/12)

A novel series of prostaglandin analogues with a seven-membered ring scaffold was designed, synthesized, and evaluated for the functional activation of prostaglandin receptors to identify potent and subtype-selective FP and EP3 dual agonists. Starting fro

BICYCLIC COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES

-

, (2014/01/07)

Provided is a compound which has strong and sustaining intraocular pressure lowering action and, further, has no fear of side effect on eyes. Since a compound represented by the formula (I): wherein definition of each group is as described in the specific

BICYCLIC COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES

-

, (2012/05/21)

Since a compound represented by the general formula (I) (wherein definition of each group is as described in the specification), a salt thereof, a solvate thereof, or a prodrug thereof has strong and sustaining intraocular pressure lowering activity and,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1262872-82-1